Biotech · Private company
Aegerion Pharmaceuticals, Inc.
Track this companyFree. Adds Aegerion Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- AtorvastatinPhase 1 · Effect of Atorvastatin on the Pharmacokinetics of LomitapideClinicalTrials.gov · fetched Nov 12, 2026
- EE/norgestimatePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- lomitapidePhase 1 · Effect of Atorvastatin on the Pharmacokinetics of LomitapideClinicalTrials.gov · fetched Nov 12, 2026
- lomitapidePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- MetreleptinGeneralized LipodystrophyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Immunogenicity of Metreleptin in Patients With Generalized LipodystrophyPHASE4 · COMPLETED · started Nov 14, 2018ClinicalTrials.gov NCT04026178 · fetched Nov 12, 2026
- Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female SubjectsPHASE1 · COMPLETED · started Feb 19, 2014ClinicalTrials.gov NCT02080468 · fetched Nov 12, 2026
- Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects.PHASE1 · COMPLETED · started Jan 27, 2014ClinicalTrials.gov NCT02080455 · fetched Nov 12, 2026